The treatment results of patients with locally advanced esophageal carcinomas have
evolved since the publication of the first trial of concurrent mitomycin C and 5-fluorouracil …

Abstract Learning Objectives After completing this course, the reader will be able to: Discuss
the epidemiology of esophageal cancer. Explain the current status of diagosing and treating …

BACKGROUND In patients with locoregional carcinoma of the esophagus or
esophagogastric junction who underwent preoperative chemoradiation, it is unclear whether …

Background We conducted a prospective randomized controlled trial comparing surgery
alone (S) with concurrent chemoradiotherapy followed by surgery (CRT-S) for resectable …

Written by world-class experts in clinical cancer therapeutics, Physicians' Cancer
Chemotherapy Drug Manual 2017 provides a complete, easy-to-use catalog of over 100 …

Background: There is no general agreement on the effect of neoadjuvant treatment for
esophageal cancer on patient survival. Methods: A meta-analysis was performed to …

BACKGROUND: Patients with esophageal cancer who receive neoadjuvant
chemoradiotherapy are restaged with computed tomography (CT), endoscopic ultrasound …

Purpose Understanding how specific genetic variants modify drug action pathways may
provide informative blueprints for individualized chemotherapy. Methods We applied a …

Written by world-class experts in clinical cancer therapeutics, Physicians' Cancer
Chemotherapy Drug Manual 2020 provides a complete, easy-to-use catalog of over 100 …

Importance Distant recurrence following preoperative chemoradiotherapy and resection in
patients with gastroesophageal adenocarcinoma is common. Adjuvant chemotherapy may …